FIELD: medicine, phytotherapy. SUBSTANCE: invention proposes a species consisting of 19 medicinal plants taken at the definite ratio. Treatment with the proposed species results to the absence of adverse effects (toxic effect on the liver, cholagogic effect, allergic responses) as compared with the known enzyme preparations. Also, treatment results to the persistence remission of the patient state. EFFECT: enhanced effectiveness of treatment, absence of adverse effects. 1 cl, 2 tbl, 4 ex
| Title | Year | Author | Number |
|---|---|---|---|
| AGENT FOR TREATMENT OF CHRONIC VIRAL HEPATITIS B | 2000 |
|
RU2180228C1 |
| AGENT FOR TREATMENT OF PATIENTS WITH CHRONIC CHOLESTATIC HEPATITIS | 2000 |
|
RU2175869C1 |
| AGENT FOR TREATMENT OF PATIENTS WITH HEPATITIS AND FIBROSIS SYMPTOMS | 2000 |
|
RU2164802C1 |
| AGENT FOR TREATMENT OF CHRONIC PYELONEPHRITIS | 2001 |
|
RU2224531C2 |
| AGENT FOR TREATMENT OF PATIENTS WITH CHRONIC HEPATITIS OF AN INFECTIOUS ETIOLOGY | 1996 |
|
RU2122418C1 |
| AGENT FOR TREATMENT OF LIVER CIRRHOSIS ACCOMPANYING WITH ASCITIS | 2001 |
|
RU2224532C2 |
| AGENT FOR TREATMENT OF STOMACH AND DUODENUM ULCER DISEASE WITH ERADICATION OF HELICOBACTER PYLORI OCCURRING ON BACKGROUND OF LIVER CHRONIC DISEASES | 2004 |
|
RU2274467C2 |
| MEDICATION FOR TREATING INTESTINAL DYSBIOSIS IN PATIENTS WITH CHRONIC CRYPTOGENIC HEPATITIS | 2009 |
|
RU2411955C1 |
| MEDICATION FOR TREATMENT OF PATIENTS WITH DRUG HEPATITIS | 2009 |
|
RU2419449C1 |
| AGENT FOR TREATMENT OF UROLITHIASIS | 2005 |
|
RU2281781C1 |
